BridgeBio Pharma BBIO CA — Operating Loss Carryforwards

Similar metrics at other companies

ROIVOther Jurisdictions — Operating Loss Carryforwards

$67.7M—

OHIGB — Operating Loss Carryforwards

$47.8M—

ROIVTax Authority In Other Jurisdictions — Operating Loss Carryforwards

$98.4M—

TTDGB — Operating Loss Carryforwards

$326.6M+153%

OVVCA — Operating Loss Carryforwards

$381M-52.8%

TTMICN — Operating Loss Carryforwards

$8.81M-73.6%

Questions, answered.

What is BridgeBio Pharma's CA — operating loss carryforwards?

BridgeBio Pharma (BBIO) reported CA — operating loss carryforwards of $229.2M in Q4 2021.

What does CA — operating loss carryforwards mean?

The total amount of past operating losses in a specific region that can be used to reduce future tax bills.

How do you interpret CA — operating loss carryforwards?

An increase indicates continued heavy investment in R&D or operational losses, while a decrease suggests the segment is either utilizing these losses against profits or that the tax assets are expiring.

How does CA — operating loss carryforwards compare across companies?

High-growth biotech companies typically report significant operating loss carryforwards due to the long-term nature of drug development and the time required to reach commercialization.